2015 annual financial data
Rigel Pharmaceuticals 2015 Operating margin
Direct answer
Operating margin was -179.07%.
Operating income was -51,743,000 USD and net income was -51,464,000 USD.
Operating cash flow was -23,413,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,895,000 USD
- Operating income
- -51,743,000 USD
- Net income
- -51,464,000 USD
- Operating cash flow
- -23,413,000 USD